Jane Street’s Grace Therapeutics GRCE Stock Holding History

Jane Street’s Portfolio GRCE Stock Details GRCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$203K	Sell	89,442 -77,655	-46%	-$215K	﹤0.01%	10101
2026 Q1	$774K	Buy	+167,097	New	+$656K	﹤0.01%	7060
2023 Q3	–	Sell	-2,369	Closed	-$7.46K	–	9535
2023 Q2	$7.46K	Buy	+2,369	New	+$7.07K	﹤0.01%	8463
2022 Q1	–	Sell	-3,067	Closed	-$23K	–	11159
2021 Q4	$23K	Sell	3,067 -86	-3%	-$776	﹤0.01%	9767
2021 Q3	$38K	Buy	+3,153	New	+$62.1K	﹤0.01%	9630
2021 Q2	–	Sell	-2,096	Closed	-$60K	–	10541
2021 Q1	$60K	Buy	+2,096	New	+$72.7K	﹤0.01%	8795
2020 Q3	–	Sell	-271	Closed	-$6K	–	8069
2020 Q2	$6K	Buy	+271	New	+$7.9K	﹤0.01%	7001
2016 Q2	–	Sell	-215	Closed	-$16K	–	4697
2016 Q1	$16K	Buy	+215	New	+$16.8K	﹤0.01%	3986
2014 Q3	–	Sell	-62	Closed	-$30K	–	3151
2014 Q2	$30K	Buy	+62	New	+$29.6K	﹤0.01%	2460

Other funds holding GRCE

Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Maven Securities St Helier, Jersey $5.06B AUM 59.27% 1-Year Est. Return

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Jane Street's GRCE Position: Q2 2026 in Review

Jane Street reduced its Grace Therapeutics (GRCE) stake by 46% in Q2 2026, selling an estimated $215K and leaving 89,442 shares worth $203K. The position accounts for ﹤0.01% of the portfolio, ranked #10101.

Jane Street first reported a position in GRCE in Q2 2014 and has held it in 9 quarters since. The position peaked at $774K in Q1 2026. 33 funds tracked by Wall St. Rank hold GRCE as of Q2 2026.

Jane Street held 89,442 shares of Grace Therapeutics worth $203K as of Q2 2026.
Jane Street sold 77,655 Grace Therapeutics shares in Q2 2026, an estimated $215K.
Grace Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10101 holding.
Jane Street first reported a position in Grace Therapeutics in Q2 2014 and has held it in 9 quarters since.
Jane Street's Grace Therapeutics position peaked at $774K in Q1 2026.
33 funds tracked by Wall St. Rank held Grace Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.